SK Biopharmaceuticals Logo

SK Biopharmaceuticals

🇰🇷
326030
KR7326030004

SK Biopharmaceuticals is an innovative South Korean pharmaceutical company dedicated to the research and development of novel medicines. The company develops and markets therapies for CNS disorders and oncology, aiming to sustainably improve the quality of life for patients worldwide.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will SK Biopharmaceuticals report its next quarterly earnings?

SK Biopharmaceuticals is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did SK Biopharmaceuticals last report quarterly earnings?

SK Biopharmaceuticals last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 581.55 KRW.

How does SK Biopharmaceuticals stock react to earnings?

Across its last 5 earnings reports, SK Biopharmaceuticals stock moved by ±5% on average the following day. The largest reaction was +17.2% on 02/06/2025; 4 of 5 reactions were positive.

How often has SK Biopharmaceuticals beaten expectations?

SK Biopharmaceuticals has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the SK Biopharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:₩594.78
Actual:
Q2 2026
Beat
Estimate:₩563.67
Actual:₩581.55
Difference:+₩17.88
Price reaction (1 day):+2.8 %
Q1 2026
Beat
Estimate:₩481.02
Actual:₩1,311.79
Difference:+₩830.77
Price reaction (1 day):+1.1 %
Price reaction (7 days):+4.0 %
Q4 2025
Beat
Estimate:₩434.02
Actual:₩1,694.99
Difference:+₩1,260.97
Price reaction (1 day):-2.7 %
Price reaction (7 days):-2.1 %
Q3 2025
Beat
Estimate:$342.46
Actual:$947.00
Difference:+$604.54
Price reaction (1 day):+1.4 %
Price reaction (7 days):+0.7 %
Q1 2025
Beat
Estimate:$390.33
Actual:$420.00
Difference:+$29.67
Q4 2024
Estimate:
Actual:
Price reaction (1 day):+17.2 %
Price reaction (7 days):+15.7 %

Earnings statistics

Stock reaction to earnings

±5%
Avg. next-day move
+17.2%
Largest move (02/06/2025)
80%
Share of positive reactions
±5.6%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+93.7%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
SK Biopharmaceuticals
Ticker Symbol
326030
ISIN
KR7326030004
Country
🇰🇷
Korea, Republic of
Sector